We found significant shortening of overall survival time (OS) for patients without CYP24A1 in primary melanomas (581 days vs. 1449 days for melanomas with low CYP24A1, and 2297 days for melanomas with high CYP24A1) (Figure 4A). Here, CYP24A1 is linked to melanoma.